Transdermal [ftcn]
17 beta-Estradiol [horm, phsu, strd]
glucose metabolism [moft]
postmenopausal [tmco]
Women [popg]
Oral [spco]
Intravenous [spco]
Glucose [bacs, carb, phsu]
Administration [ocac]
objectives [inpr]
Evaluate [ftcn]
Transdermal [ftcn]
17 beta-Estradiol [horm, phsu, strd]
MU/day [qnco]
glucose metabolism [moft]
postmenopausal [tmco]
Women [popg]
Study Design [resa]
Frequently [tmco]
sampled [diap]
Intravenous Glucose Tolerance Test [diap]
Calculate [acty]
Insulin Sensitivity [patf]
Peripheral [spco]
Glucose [bacs, carb, phsu]
utilization [ftcn]
Insulin [aapp, horm, phsu]
Oral Glucose Tolerance Test [diap]
75 g [qnco]
OGTT [diap]
Performed [ftcn]
Nine [qnco]
postmenopausal [tmco]
Women [popg]
2 Months [tmco]
treatment [ftcn]
Estradiol [horm, phsu, strd]
Decreased [qnco]
Insulin [aapp, horm, phsu]
Increased [qnco]
C-Peptide [aapp, bacs]
Insulin [aapp, horm, phsu]
Ratio [qnco]
Fasting [fndg]
P NOS [aapp, imft]
OGTT [diap]
insulin levels [lbpr]
P NOS [aapp, imft]
C-Peptide [aapp, bacs]
Insulin [aapp, horm, phsu]
Ratio [qnco]
P NOS [aapp, imft]
Frequently [tmco]
sampled [diap]
Intravenous Glucose Tolerance Test [diap]
glucose levels [lbtr]
c peptide levels [lbpr]
Sensitivity [qnco]
Affected [ftcn]
Conclusions [idcn]
Sensitivity [qnco]
reduction [npop]
insulin levels [lbpr]
C-Peptide [aapp, bacs]
Insulin [aapp, horm, phsu]
Ratio [qnco]
Observed [ftcn]
Fasting [fndg]
OGTT [diap]
Support [medd]
Estradiol [horm, phsu, strd]
glucose metabolism [moft]
Probably [idcn]
Estradiol [horm, phsu, strd]
gastrointestinal [spco]
Science [ocdi]
Ireland [geoa]
LTD [ortf]
